Covid-19, Preeclampsia, Pregnancy Related
Conditions
Keywords
covıd-19, pregnancy, preeclampsia, preeclampsia-like syndrome
Brief summary
By applying polymerase chain reaction (PCR) test for Covid-19 to preeclampsia patients who applied to our hospital during the Covid-19 pandemic period, we investigated the frequency of Covid-19 related preeclampsia-like syndrome in this patient group.
Detailed description
The investigators studied the frequency of Covid-19 related preeclampsia-like syndrome by PCR test and lung ultrasound for Covid-19 to preeclampsia patients presenting to the instutution during the Covid-19 pandemic period. The first consecutive 100 preeclampsia patients presented to our hospital during the pandemic will be involved in our study. The primary outcome measure is to detect Covid-19 positivity among the preeclamptic pregnant women..
Interventions
PCR for Covid-19
Sponsors
Study design
Eligibility
Inclusion criteria
* First consecutive 100 pregnant women presenting with preeclamptic symptoms and signs between March 15, 2020 and June 1, 2020.
Exclusion criteria
* The pregnancies with known diagnosis of preeclampsia before Covid-19 pandemic * Preeclamptic patient without a Covid-19 PCR test result * Pregnant women who does not want to participate in study or does not want their personal informations to be shared * Pregnant women less than 18 years old and more than 40 years old are excluded
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| PCR positivity | 3 months | To detect Covid-19 PCR test positivity among preeclamptic pregnant women |
Countries
Turkey (Türkiye)